Showing results (351-360 of 385) with videos related to

Sort By:
Pageof 39
Cardiovascular Intervention and Therapeutics|April 4, 2021
Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacyPing-Yen Liu, Cheng-Huang Su, Feng-Yu Kuo, et al.
International Heart Journal|September 2, 2016
Analysis of the Clinical Characteristics, Management, and Causes of Death in Patients with ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention from 2005 to 2014Po-Tseng Lee, Ting-Hsing Chao, Ya-Ling Huang, et al.
The Journal of Pathology|November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumoursSubbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.
Cancer Research|January 14, 2021
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic VulnerabilityRaunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, et al.
The American Journal of Surgical Pathology|June 19, 2018
Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 FusionsBrendan C Dickson, Cristina R Antonescu, Prokopios P Argyris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2020
High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalitiesYouran Zou, Gulisa Turashvili, Robert A Soslow, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2016
An Immunohistochemical Algorithm for Ovarian Carcinoma TypingMartin Köbel, Kurosh Rahimi, Peter F Rambau, et al.
The American Journal of Surgical Pathology|October 2, 2025
PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 FusionCarina A Dehner, Jorge Torres-Mora, Judith Jebastin Thangaiah, et al.
Molecular Cancer Therapeutics|October 5, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMarta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, et al.
Acta Cardiologica Sinica|April 29, 2016
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein ThrombosisKang-Ling Wang, Pao-Hsien Chu, Cheng-Han Lee, et al.
Pageof 39